For the full mechanism explainer including how GcgR's glucose-raising effect is offset by GLP-1R co-agonism, see the Glucagon Receptor Explained entity page
Ozempic (semaglutide), the type 2 diabetes drug that can be prescribed off-label for weight loss , is known for a range of side effects, from abdominal pain to Ozempic butt . Usually, Ozempic doesnt cause joint and muscle pain, although some people report it while taking the drug
CrossRef Ononin Inhibits the Growth and Metastasis of Hepatocellular Carcinoma by Suppressing MMP2 and MMP9 via PI3K/AKT/mTOR Signaling Shasha Peng, Jun Guo, Hongfei Fu Journal of Biochemical and Molecular Toxicology .2026;[Epub] CrossRef Global landscape of yttrium-90 clinical trials: a systematic registry-based analysis Qianwen Ni, Kenan Wang, Wenyi Jin, Yakun Gao, Ping Gong, Zhenguang Wang, Zheqi Xu, Hui Liu, Susu Luo Trials .2026;[Epub] CrossRef Artificial Intelligence and Radiomics in Primary Liver Cancer Imaging: A Bibliometric and Visualized Analysis Ruizhi Fu, Chen Gao, Xinjing Lou, Ziqing Han, Yizhen He, Chenye Zheng, Zhuping Yu, Hongsheng Chang Journal of Hepatocellular Carcinoma .2026
For Wegovy at the higher 2.4 mg weight management dose, the incidence jumps to approximately 7% of adults
Category 3: The persistent experimenters (approximately 10%)
GLP-1R is not only a key target for metabolic regulation but also a bridge between metabolism and the nervous system